MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "etc): Treatment"

  • 2019 International Congress

    Management of life threatening dyskinesias in GNAO1 related movement disorder: two new cases and review of the literature

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: To present two cases of GNAO1 related movement disorder associated with life threatening persistent chorea successfully managed with bilateral GPi deep brain stimulation (GPi-DBS)…
  • 2019 International Congress

    Pediatric anti-N-methyl-D-aspartate receptor encephalitis associated with Coat’s-like retinal telangiectasia

    N. Kumar, D. Radhakrishnana, R. Shree, G. Madhaw, R. Samanta, S. Kumari (Rishikesh, India)

    Objective: We report a case of 5-year-old Indian boy with non-paraneoplastic anti NMDAR encephalitis associated with Coat's like retinal telangiectasia. Background: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis…
  • 2017 International Congress

    The Long-Term Safety of Deutetrabenazine for Chorea in Huntington Disease

    S. Frank, C. Vaughan, D. Stamler, D. Oakes, M. Davis, S. Eberly, E. Kayson, J. Whaley, J. Goldstein, C. Testa (Boston, MA, USA)

    Objective: To evaluate the safety and tolerability of deutetrabenazine in Huntington Disease (HD) over long term exposure. Background: In a randomized, double-blind, controlled trial (First-HD),…
  • 2017 International Congress

    Inhibiting sphingosine-1-phosphate lyase as a possible therapy in Huntington’s disease

    E. Furr Stimming, J.F. Manchon, A. Tsvetkov (Houston, TX, USA)

    Objective:  To advance our understanding of the process by which the mutant huntingtin (mHTT) protein contributes to neurodegeneration and translate that knowledge to potentially effective disease…
  • 2017 International Congress

    Prescription pattern of treatment in Mexican patients with Huntington’s Disease.

    A. De-la-Cruz, L. Mendoza Vega, N. Davila Avila, K. Salinas Barboza, S. Isais Millan, A. Cervantes Arriaga, M. Rodriguez Violante (Ciudad de Mexico, Mexico)

    Objective: To describe the prescription pattern for the treatment of HD in a sample of Mexican patients from a tertiary referral center. Background: Huntington’s disease…
  • 2017 International Congress

    Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

    Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians   Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…
  • 2017 International Congress

    Factors Influencing Completion of Predictive Testing for Huntington’s Disease (HD)

    M. Patel, V. Sung (Birmingham, AL, USA)

    Objective: To determine if the new simplified testing protocol led to an increase in completion rate of predictive testing for HD, and to study some…
  • 2017 International Congress

    Long-Term Dopamine Transporter Imaging and Clinical Effects of the Mixed-Lineage Kinase Inhibitor CEP-1347 in the PRECEPT Parkinson Trial

    I. Shoulson, S.E. Eberly, D. Oakes, A. Lang, M. Schwarzschild, C. Tanner, J. Seibyl, K. Marek (Washington, DC, USA)

    Objective: To assess the imaging and clinical effects of CEP-1347 after treatment discontinuation  in the Parkinson Research Examination of CEP-1347 Trial (PRECEPT), a multi-center randomized…
  • 2017 International Congress

    Syndenham’s chorea in Senegalese children: A case series

    F.S. NGOUNGOURE HALIMA, M. NDIAYE, A.D. SOW, B. SECK, M.M. NDIAYE (Dakar, Senegal)

    Objective: To describe clinical profile and treatment outcome of Sydenham’s chorea (SC) in children attending a tertiary care hospital in Dakar, Senegal. Background: SC is…
  • 2017 International Congress

    Effects of bilateral pallidal deep brain stimulation for chorea after pulmonary thromboendarterectomy with deep hypothermia and circulatory arrest: case report

    K. Aoyagi, Y. Higuchi, Y. Okahara, Y. Yamanaka, T. Yamamoto, S. Hirano, Y. Iwadate (Ichihara, Japan)

    Objective: We report bilateral pallidal deep brain stimulation (DBS) improved chorea after pulmonary thromboendarterectomy (PTE) with deep hypothermia and circulatory arrest. Background: Chronic thromboembolic pulmonary…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley